HTS157M Sigma-AldrichChemiSCREEN™ Human α2B Adrenergic Receptor Membrane Preparation
Human alpha2B GPCR membrane prepation for Radioligand binding Assays.
More>> Human alpha2B GPCR membrane prepation for Radioligand binding Assays. Less<<Prodotti consigliati
Panoramica
Replacement Information |
---|
Tabella delle specifiche principali
Species | Host Cells | Protein Target |
---|---|---|
Human | Chem-1 | alpha2B |
References |
---|
Product Information | |
---|---|
Format | Membranes |
Presentation | One package contains enough membranes for at least 200 assays (units), where a unit is the amount of membrane that will yield greater than 20-fold signal:background with 3H-labeled Rauwolscine at 15 nM Liquid in packaging buffer: 50 mM Tris pH 7.4, 10% glycerol and 1% BSA with no preservatives. |
Quality Level | MQ100 |
Applications | |
---|---|
Application | Human alpha2B GPCR membrane prepation for Radioligand binding Assays. |
Key Applications |
|
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Storage and Shipping Information | |
---|---|
Storage Conditions | Maintain frozen at -70°C for up to 2 years. Do not freeze and thaw. |
Packaging Information | |
---|---|
Material Size | 200 units |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Numero di catalogo | GTIN |
HTS157M | 04053252471032 |
Documentation
ChemiSCREEN™ Human α2B Adrenergic Receptor Membrane Preparation MSDS
Titolo |
---|
ChemiSCREEN™ Human α2B Adrenergic Receptor Membrane Preparation Certificati d'Analisi
Titolo | Numero di lotto |
---|---|
CHEMISCREENTM MEMBRANE PREPARATION RECOMBINANT HUMAN #945;2B ADRENERGIC RECEPTOR - 2106989 | 2106989 |
Riferimenti bibliografici
Panoramica dei riferimenti bibliografici | Codice d'identificazione nel Pub Med |
---|---|
In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors Kable, J W, et al J Pharmacol Exp Ther, 293:1-7 (2000) 1999 | 10734146 |